Making More Health Accelerator Program 2023: Receive Financial and Investor access Support

Closing Date: 13-Jan-23

Applicants are invited to submit their applications for the Making More Health Business Accelerator Program, a structured business growth program targeted at social entrepreneurs with innovative solutions in the health sector. The program offers two engagement phases.

Phase 1, called the “Pilot Phase”, runs for 12 months and focuses on supporting entrepreneurs to:

  • identify strategic challenges and/or opportunities related to the growth, sustainability and impact of their social enterprises
  • co-create and test relevant solutions.

Phase 2, called the “Scale-up Phase” also runs for 12 months and focuses on supporting participants to scale up successful solutions from the first phase of engagement. In both phases, participating entrepreneurs are provided with access to technical support from Boehringer Ingelheim employees, strategic networks, financial resources, and a platform to collaborate, learn and engage with fellow social entrepreneurs and other ecosystem actors.

Focus Areas:

The accelerator broadly focuses on supporting social entrepreneurs with innovative solutions aimed at advancing access to healthcare in Sub-Saharan Africa. Solutions may be both in the animal or human health field. The specific countries from which they are currently selecting participants are Kenya, Uganda, Rwanda, Nigeria, and Ghana.

Human health: Human healthcare care solutions of interest broadly include any innovation that is tackling barriers to awareness, access, affordability, and availability of healthcare services in underserved communities. Of particular interest are innovations that are addressing non-communicable (NCDS) as the main area of focus or as a core part of a broader intervention scope. NCDS include diabetes, hypertension, myocardial infarction, stroke, respiratory disease, and cancers.

Animal health: Animal Health is a critical part of healthcare, and they are interested in supporting the most innovative solutions tackling barriers to awareness, access, affordability, and availability of animal healthcare. Of particular interest are solutions at the last mile as well as those tackling issues related to human-animal transmission.


  • Knowledge access.
  • Technical expertise.
  • Strategic networks.
  • Financial and investor access support.
  • Business collaboration.


You should apply for the program if you have an innovative human or animal health solution that fits the description provided and if you meet the criteria.

  • Legal Entity: Company limited by guarantee, Limited liability company, NGO.
  • Age: At least three years of operation.
  • Sector: Human or animal health related.
  • Country of operation: Ghana, Nigeria, Kenya, Uganda, and Rwanda.
  • Revenue: At least USD 100K in annual sales revenue.
  • Impact: Evidence of social impact with clearly defined impact metrics.

For more information, visit

Leave a Reply

Your email address will not be published.

19 + eleven =

Subscribe To Our Newsletter

Related Post